TechMARK movers: Rapid growth for NCC

19th Oct 2010 13:37

NCC has grown its revenues by one-third in the first four months of its financial year. The software escrow and assurance testing company says that most of the growth is coming from the assurance division where organic growth has been supplemented by acquisitions. The order book is worth £17.7m. NCC plans to increase its escrow prices. Renewals totalling £15.2m are expected in the year to May 2011. Net debt is £22.2m after last week's acquisition of iSEC. Interim figures to November 2010 will be published on 20 January. Biocompatibles International continues to fall after last Friday's announcement that it did not expect £3m of sales from Novabel, which is injected into the skin in order to shape and define the face. There may even be a write-down in the next accounts because of a safety scare. Bid talks continue. FTSE TechMARK - RisersNetwork Technology (NTY) 650.00p +8.33%Ark Therapeutics Group (AKT) 4.75p +7.37%Dialight (DIA) 450.00p +7.02%Asterand (ATD) 12.50p +4.17%NCC Group (NCC) 460.00p +3.37%Autonomy Corporation (AU.) 1,463.00p +3.10%ProStrakan Group (PSK) 77.00p +1.59%Anite (AIE) 52.50p +1.45%Intec Telecom Systems (ITL) 73.50p +1.38%Oxford Biomedica (OXB) 9.61p +1.16%Kewill (KWL) 102.00p +1.08%FTSE TechMARK - FallersVislink (VLK) 20.00p -4.76%AEA Technology (AAT) 5.30p -4.17%Biocompatibles International (BII) 329.00p -3.80%NXT (NTX) 4.00p -3.15%Gresham Computing (GHT) 20.75p -2.65%ARM Holdings (ARM) 389.60p -2.38%Sepura (SEPU) 43.00p -2.27%Alterian (ALN) 200.25p -2.03%Innovation Group (TIG) 13.50p -1.82%Renovo Group (RNVO) 30.00p -1.64%Psion (PON) 91.00p -1.62%